市場調査レポート
商品コード
1494344

アジア太平洋の流動性止血剤市場の2028年までの予測- 地域別分析- 材料、製品、用途、エンドユーザー別

Asia Pacific Flowable Hemostats Market Forecast to 2028 - Regional Analysis - by Material, Product, Application, and End User

出版日: | 発行: The Insight Partners | ページ情報: 英文 138 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
アジア太平洋の流動性止血剤市場の2028年までの予測- 地域別分析- 材料、製品、用途、エンドユーザー別
出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 138 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の流動性止血剤市場は、2022年の1億7,664万米ドルから2028年には2億7,519万米ドルに成長すると予測されています。2022年から2028年までのCAGRは7.7%を記録すると推定されます。

病院と手術センターの増加がアジア太平洋の流動性止血剤市場を活性化

負傷は依然として公衆衛生にとって重大な懸念事項です。世界の外傷や事故事例の増加は、アジア太平洋の流動性止血剤市場の主要な促進要因です。世界保健機関(WHO)によると、年間約130万人が交通事故により命を落としています。2,000万人から5,000万人が非致死的な負傷を負い、その多くが負傷のために障害を負っています。世界全体では、出血または過剰出血が病院前死亡の3分の1以上、最初の24時間以内の死亡の40%以上を占めています。スポーツ、労働災害、加齢による機能障害に関連した筋骨格系障害の増加により、手術件数は増加しています。しかし、健康増進のかなりの割合が、スポーツ関連の怪我によって失われています。国立医学図書館の報告書によると、中国は他の国に比べて外傷性脳損傷(TBI)患者の数が多く、この状態が公衆衛生上の大きな懸念となっています。このように、怪我や外科手術の増加が流動性止血剤の高い採用率の原因となっており、予測期間中の市場の成長を牽引しています。

アジア太平洋の流動性止血剤市場概要

アジア太平洋の流動性止血剤市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋地域に区分されます。アジア太平洋地域は、他のすべての地域の中で最も急成長している地域であると予想されます。アジア太平洋地域の市場成長は、ヘルスケア部門のインフラ開拓への投資、手術件数の増加、優れた手術結果の提供を重視する傾向の高まり、有利な規制当局の承認などにより、より速いペースで成長すると予想されます。アジア太平洋の流動性止血剤市場では、中国が大きなシェアを占めています。同市場は、優れた外科治療を提供することが重視されるようになり、最新のヘルスケア器具に対する需要が高まっていることから、成長が見込まれています。出血性疾患の有病率の増加は、流動性止血剤の設計、開発、試験運用に道を開いています。Hemophilia Treatment Center Collaboration Network of China(HTCCNC)の調査によると、HTCCNCは2007年から2019年までに17,779人の血友病A患者を確認しました。患者は男性が多く(99.99%)、28.3%に血友病の家族歴が判明していました。検査で重症度が測定された患者(N=13,116)のうち、6,519人が重症HA(49.7%)、4,788人が中等症HA(36.5%)、1,809人が軽症HA(13.8%)でした。このように、血友病の罹患率の増加は、予測期間中に流動性止血剤の需要を増加させるであろう。

アジア太平洋の流動性止血剤市場の収益と2028年までの予測(金額)

アジア太平洋の流動性止血剤市場のセグメンテーション

アジア太平洋の流動性止血剤市場は、材料、製品、用途、エンドユーザー、国に区分されます。

材料別では、アジア太平洋の流動性止血剤市場は牛ゼラチンと豚ゼラチンに二分されます。2022年のアジア太平洋の流動性止血剤市場では、牛ゼラチン分野が大きなシェアを占めています。

製品別では、アジア太平洋の流動性止血剤市場は、コンビネーション止血剤、パッシブ止血剤、アクティブ止血剤に区分されます。2022年のアジア太平洋地域の流体式止血剤市場では、コンビネーション止血剤が最大のシェアを占めています。

用途別に見ると、アジア太平洋の流動性止血剤市場は、一般外科、心臓外科、血管外科、整形外科、神経・脊椎外科、その他に分類されます。2022年のアジア太平洋の流動性止血剤市場では、一般外科分野が最大のシェアを占めています。

エンドユーザー別に見ると、アジア太平洋の流動性止血剤市場は、病院・診療所、外来手術センター、その他に区分されます。2022年のアジア太平洋の流動性止血剤市場では、病院・診療所市場が最大のシェアを占めています。

国別では、アジア太平洋の流動性止血剤市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋地域に分類されます。2022年のアジア太平洋の流動性止血剤市場は中国が独占。

Baxter International Inc、Ethicon(Johnson &Johnson)、Pfizer Inc、Teleflex Incorporated、3-D Matrix Medical Technology、Aegis Lifesciencesは、アジア太平洋の流動性止血剤市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 要点

第3章 調査手法

  • カバー範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の流動性止血剤市場- 市場情勢

    • アジア太平洋地域のPEST分析
  • アジア太平洋の専門家の見解

第5章 アジア太平洋の流動性止血剤市場-主要市場力学

  • 市場促進要因
    • 怪我や外科手術の増加
    • 老人人口の増加
  • 市場抑制要因
    • 熟練専門家の不足と不十分な償還政策
  • 市場機会
    • 病院数と手術センター数の増加
  • 今後の動向
    • 製品革新につながる研究開発(R&D)活動
  • 影響分析

第6章 流動性止血剤市場:アジア太平洋地域の分析

  • アジア太平洋の流動性止血剤市場収益と予測分析
    • アジア太平洋の流動性止血剤市場の収益予測と分析

第7章 アジア太平洋の流動性止血剤市場分析-素材別

  • アジア太平洋の流動性止血剤市場:材料別シェア(2021年、2028年)
  • 牛ゼラチン
  • 豚ゼラチン

第8章 アジア太平洋の流動性止血剤の市場分析-製品別

  • アジア太平洋の流動性止血剤市場:製品別シェア、2021年および2028年(%)
  • コンビネーション止血剤
    • コンビネーション止血剤アジア太平洋の流動性止血剤市場-2028年までの収益と予測
  • パッシブ止血剤
    • パッシブ止血剤:アジア太平洋の流動性止血剤市場-2028年までの収益と予測
  • 活性型止血剤
    • 活性止血剤:アジア太平洋の流動性止血剤市場-2028年に至る収益と予測

第9章 流動性止血剤のアジア太平洋市場:用途別

  • アジア太平洋の流動性止血剤市場:用途別シェア(2021年、2028年)
  • 一般外科
    • 一般外科アジア太平洋の流動性止血剤市場-2028年までの収益と予測
  • 心臓外科
    • 心臓外科:アジア太平洋の流動性止血剤市場:収益と2028年までの予測
  • 血管外科
    • 血管外科アジア太平洋の流動性止血剤市場:収益と2028年までの予測
  • 整形外科
    • 整形外科の概要
    • 整形外科アジア太平洋の流動性止血剤市場:収益と2028年までの予測
  • 神経・脊椎外科
    • 神経・脊椎外科:アジア太平洋の流動性止血剤市場-2028年に至る収益と予測
  • その他
    • その他
    • その他アジア太平洋の流動性止血剤市場:2028年に至る収益と予測

第10章 アジア太平洋の流動性止血剤の市場分析:エンドユーザー別

  • アジア太平洋の流動性止血剤市場:エンドユーザー別シェア(2021年、2028年)
  • 病院および診療所
  • 外来手術センター
  • その他

第11章 アジア太平洋の流動性止血剤市場の収益と2028年までの予測:国別分析

  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域

第12章 流動性止血剤の市場-業界情勢

  • 流動性止血剤市場における成長戦略(%)
  • 有機的展開
  • 無機的展開

第13章 企業プロファイル

  • Baxter International Inc
  • Ethicon(Johnson & Johnson)
  • Pfizer Inc.
  • Teleflex Incorporated
  • 3-D Matrix Medical Technology
  • Aegis Lifesciences

第14章 付録

図表

List Of Tables

  • Table 1. China: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 2. China: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 3. China: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 4. China: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 5. Japan: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 6. Japan: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 7. Japan: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 8. Japan: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 9. India: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 10. India: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 11. India: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 12. India: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 13. South Korea: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 14. South Korea: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 15. South Korea: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 16. South Korea: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 17. Australia: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 18. Australia: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 19. Australia: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 20. Australia: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 21. Rest of Asia Pacific: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 22. Rest of Asia Pacific: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 23. Rest of Asia Pacific: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 24. Rest of Asia Pacific: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 25. Organic Developments in the Flowable Hemostats Market
  • Table 26. Inorganic Developments in the Flowable Hemostats Market
  • Table 27. Asia Pacific Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Flowable Hemostats Market Segmentation
  • Figure 2. Asia Pacific Flowable Hemostats Market, By Country
  • Figure 3. Asia Pacific Flowable Hemostats Market Overview
  • Figure 4. Bovine Gelatin Holds Maximum Share in Asia Pacific Flowable Hemostats Market
  • Figure 5. Asia Pacific Flowable Hemostats Market, by Country (US$ Million)
  • Figure 6. Asia Pacific Flowable Hemostats Market, Market Attractiveness
  • Figure 7. Asia Pacific: PEST Analysis
  • Figure 8. Asia Pacific Experts Opinion
  • Figure 9. Impact Analysis
  • Figure 10. Asia Pacific Flowable Hemostats Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 11. Asia Pacific Flowable Hemostats market Share, by Material, 2021 and 2028 (%)
  • Figure 12. Bovine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Porcine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Asia Pacific Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
  • Figure 15. Combination Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Passive Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Active Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Asia Pacific Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
  • Figure 19. General Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Cardiac Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Vascular Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Orthopedic Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Neuro and Spine Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Asia Pacific Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)
  • Figure 26. Hospitals and Clinics: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Ambulatory Surgery Centers: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Others: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Asia Pacific Flowable Hemostats Market Revenue Overview, by Country, 2021 (US$ MN)
  • Figure 30. Asia Pacific: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
  • Figure 31. China: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 32. Japan: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 33. India: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 34. South Korea: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 35. Australia: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 36. Rest of Asia Pacific: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 37. Growth Strategies in the Flowable Hemostats Market (%)
目次
Product Code: BMIRE00029829

The Asia Pacific flowable hemostats market is expected to grow from US$ 176.64 million in 2022 to US$ 275.19 million by 2028. It is estimated record a CAGR of 7.7% from 2022 to 2028.

Increasing Number of Hospitals and Surgical Centers Fuels Asia Pacific Flowable Hemostats Market

Injuries are still a significant concern to public health. An increase in global trauma and accident cases is a major driver of the Asia Pacific flowable hemostats market. According to World Health Organization (WHO), annually approximately 1.3 million people cut short their lives because of a road traffic crash. Between 20 to 50 million people suffer non-fatal injuries, with many incurring a disability because of their injury. Globally, hemorrhage or excessive bleeding is responsible for over one-third of pre-hospital deaths and over 40% of deaths within the first 24 hours. The number of surgeries is rising owing to the increasing musculoskeletal disorders related with sports, occupational injuries, and age-related dysfunction. However, a substantial proportion of health gains are lost owing to sports-related injuries. The National Library of Medicine report states China as a large base of patients agonizing traumatic brain injury (TBI) compared to other countries, making this condition a major public health concern. Thus, increasing number of injuries and surgical procedures are responsible for the high adoption of flowable hemostats, thereby driving the market's growth during the forecast period.

Asia Pacific Flowable Hemostats Market Overview

The Asia Pacific flowable hemostats market is segmented into China, Japan, India, South Korea, Australia, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The growth of market in the Asia Pacific region is expected to grow at a faster pace owing to investments made in the infrastructure development of the healthcare sector, rising number of surgical procedures, growing emphasis on providing superior surgical outcomes, and favorable regulatory approvals. China holds a considerable share in the Asia Pacific flowable hemostats market. The market is expected to grow owing to the growing emphasis on providing superior surgical care, and the growing demand for modern healthcare instruments. The rise in the prevalence of bleeding disorders has paved the way for the design, development, and piloting of flowable hemostats. According to a Hemophilia Treatment Center Collaboration Network of China (HTCCNC) study, HTCCNC identified 17,779 patients with Hemophilia A from 2007 to 2019. Patients were predominantly male (99.99%), and 28.3% had a known family history of hemophilia. Among patients with lab-measured disease severity (N = 13,116), 6,519 had severe HA (49.7%), 4,788 had moderate HA (36.5%), and 1,809 had mild HA (13.8%). Thus, rising incidences of hemophilia will increase the demand for flowable hemostats during the forecast period.

Asia Pacific Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Flowable Hemostats Market Segmentation

The Asia Pacific flowable hemostats market is segmented into material , product, application, end user, and country .

Based on material, the Asia Pacific flowable hemostats market is bifurcated into bovine gelatin and porcine gelatin. The bovine gelatin segment held a larger share of the Asia Pacific flowable hemostats market in 2022.

In terms of product , the Asia Pacific flowable hemostats market is segmented into combination hemostats , passive hemostats, and active hemostats . The combination hemostats segment held the largest share of the Asia Pacific flowable hemostats market in 2022.

Based on application , the Asia Pacific flowable hemostats market is categorized into general surgery , cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others . The general surgery segment held the largest share of the Asia Pacific flowable hemostats market in 2022.

Based on end user , the Asia Pacific flowable hemostats market is segmented into hospitals and clinics , ambulatory surgery centers, and others . The hospitals and clinics segment held the largest share of the Asia Pacific flowable hemostats market in 2022.

By country, the Asia Pacific flowable hemostats market is categorized int o China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, and Aegis Lifesciences are some of the leading companies operating in the Asia Pacific flowable hemostats market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Flowable Hemostats Market - By Material
    • 1.3.2 Asia Pacific Flowable Hemostats Market - By Product
    • 1.3.3 Asia Pacific Flowable Hemostats Market - By Application
    • 1.3.4 Asia Pacific Flowable Hemostats Market - By End User
    • 1.3.5 Asia Pacific Flowable Hemostats Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Flowable Hemostats Market - Market Landscape

  • 4.1 Overview
    • 4.1.1 Asia Pacific PEST Analysis
  • 4.2 Asia Pacific Experts Opinion

5. Asia Pacific Flowable Hemostats Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Number of Injuries and Surgical Procedures
    • 5.1.2 Rising Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Number of Hospitals and Surgical Centers
  • 5.4 Future Trends
    • 5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
  • 5.5 Impact Analysis

6. Flowable Hemostats Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Flowable Hemostats Market Revenue Forecast & Analysis
    • 6.1.1 Asia Pacific Flowable Hemostats Market Revenue Forecast & Analysis

7. Asia Pacific Flowable Hemostats Market Analysis - By Material

  • 7.1 Asia Pacific Flowable Hemostats Market Share, by Material, 2021 and 2028 (%)
  • 7.2 Bovine Gelatin
    • 7.2.1 Overview
    • 7.2.2 Bovine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 7.3 Porcine Gelatin
    • 7.3.1 Overview
    • 7.3.2 Porcine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Flowable Hemostats Market- By Product

  • 8.1 Overview
  • 8.2 Asia Pacific Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
  • 8.3 Combination Hemostat
    • 8.3.1 Overview
    • 8.3.2 Combination Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Passive Hemostat
    • 8.4.1 Overview
    • 8.4.2 Passive Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Active Hemostat
    • 8.5.1 Overview
    • 8.5.2 Active Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Flowable Hemostats Market- By Application

  • 9.1 Overview
  • 9.2 Asia Pacific Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
  • 9.3 General Surgery
    • 9.3.1 Overview
    • 9.3.2 General Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Cardiac Surgery
    • 9.4.1 Overview
    • 9.4.2 Cardiac Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Vascular Surgery
    • 9.5.1 Overview
    • 9.5.2 Vascular Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Orthopedic Surgery
    • 9.6.1 Overview
    • 9.6.2 Orthopedic Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.7 Neuro and Spine Surgery
    • 9.7.1 Overview
    • 9.7.2 Neuro and Spine Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Flowable Hemostats Market Analysis - By End User

  • 10.1 Overview
  • 10.2 Asia Pacific Flowable Hemostats Market Share, by End User, 2021 and 2028, (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Ambulatory Surgery Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgery Centers: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

11. Asia Pacific Flowable Hemostats Market Revenue and Forecasts to 2028 - Country Analysis

  • 11.1 Asia Pacific: Flowable Hemostats Market
    • 11.1.1 Overview
    • 11.1.2 Asia Pacific: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
      • 11.1.2.1 China: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.1 China: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.1.2.1.2 China: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.3 China: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.4 China: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.5 China: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.2 Japan: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.1 Japan: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.1.2.2.2 Japan: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.3 Japan: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.4 Japan: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.5 Japan: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.3 India: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.1 India: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.1.2.3.2 India: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.3 India: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.4 India: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.5 India: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.4 South Korea: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.1 South Korea: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.2 South Korea: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.3 South Korea: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.4 South Korea: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.5 South Korea: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.5 Australia: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.1 Australia: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.2 Australia: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.3 Australia: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.4 Australia: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.5 Australia: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.6 Rest of Asia Pacific: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.1 Rest of Asia Pacific: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.2 Rest of Asia Pacific: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.3 Rest of Asia Pacific: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.4 Rest of Asia Pacific: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.5 Rest of Asia Pacific: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

12. Flowable Hemostats Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Flowable Hemostats Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Baxter International Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Ethicon (Johnson & Johnson)
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Pfizer Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Teleflex Incorporated
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 3-D Matrix Medical Technology
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Aegis Lifesciences
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments

14. Appendix

  • 14.1 About the Insight Partners
  • 14.2 Asia Pacific Glossary of Terms